Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer

SIMPLE SUMMARY: Neoadjuvant chemo(targeted) therapy (NCT) can downstage disease burden in breast cancer, allowing less invasive surgery. The ability of sequential hybrid [18F]FDG PET/MRI to predict the final pathologic primary tumour response to NCT in breast cancer was investigated. In addition, th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mooij, Cornelis M., van Nijnatten, Thiemo J. A., Goorts, Briete, Kooreman, Loes F. S., Raymakers, Isabel W. M., van Meijl, Silke P. L., de Boer, Maaike, Keymeulen, Kristien B. M. I., Wildberger, Joachim E., Mottaghy, Felix M., Lobbes, Marc B. I., Smidt, Marjolein L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857040/
https://www.ncbi.nlm.nih.gov/pubmed/36672354
http://dx.doi.org/10.3390/cancers15020401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857040/
https://www.ncbi.nlm.nih.gov/pubmed/36672354
http://dx.doi.org/10.3390/cancers15020401

Ejemplares similares